Actively Recruiting
Detection of Sepsis Occurrence by Using Blood Fluorescence
Led by Ningbo Medical Center Lihuili Hospital · Updated on 2024-11-14
800
Participants Needed
1
Research Sites
192 weeks
Total Duration
On this page
Sponsors
N
Ningbo Medical Center Lihuili Hospital
Lead Sponsor
U
University of Macau
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study adopted a case-control study method to explore a reagent-free, highly sensitive, and frequently screened blood fluorescence metabolite analyzer for sepsis, which can detect the emergence of inflammatory free radicals before organ damage and shorten the diagnosis time of sepsis.
CONDITIONS
Official Title
Detection of Sepsis Occurrence by Using Blood Fluorescence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy control group: physically healthy individuals with no underlying diseases and no hospitalization in the past two years
- Patients with confirmed infections and qSOFA score 2 or higher and SOFA score 2 or higher
- Patients with suspected or confirmed infections and SOFA score of 1
You will not qualify if you...
- Minors (under 18 years old)
- Pregnant individuals
- Individuals with mental illnesses
- Other vulnerable groups
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ningbo Institute of Innovation for Combined Medicine and Engineering (NIIME), Ningbo Medical Center Lihuili Hospital, Ningbo University
Ningbo, Zhejiang, China, 315010
Actively Recruiting
Research Team
F
Fei Guo, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here